Product Overview
VX-702 | T2513 | TargetMol Chemicals
CAS: 745833-23-2
Smiles: NC(=O)N(c1ccc(C(N)=O)c(n1)-c1ccc(F)cc1F)c1c(F)cccc1F
Formula: C19H12F4N4O2
Pathway: Autophagy|||MAPK
Target: p38 MAPK|||Autophagy
Receptor: N/A
Bioactivity: VX-702 is a highly specific p38α MAPK inhibitor, 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA).
Molecular Weight: 404, 325
